Hypersensitivity and allergy
Penicillin allergy: identification and management
How to assess patients for true penicillin allergy and make appropriate treatment choices.
Source: Dr P Marazzi / Science Photo Library
In this article you will learn:
- The incidence of true penicillin allergy
- The drugs to avoid in patients with penicillin allergy
- How to manage patients who experience a severe allergic reaction to an antibiotic
All forms of natural and semisynthetic penicillins, or drugs with a similar structure such as cephalosporins or carbapenems, can cause allergy. These drugs, which have a beta-lactam ring, are recognised as one of the most frequent causes of immediate and non-immediate drug reactions,,. Adverse reactions to penicillin have been reported in 0.2% per course of treatment in a large unselected cohort, and between 3.3–5% in a large drug surveillance programme,.
However, a significant number of patients labelled as ‘penicillin allergic’ are not truly allergic to the drug. As a result, these antibiotics can be withheld unnecessarily, which may subsequently affect their clinical outcomes, increase healthcare costs and contribute to the development of drug resistant bacteria.
The prevalence of penicillin hypersensitivity in the general population is unknown as no prospective studies evaluating sensitisation rates during treatment have been undertaken to date. However, from data extracted from the electronic health medical records of patients who had at least one outpatient visit, the prevalence of ‘allergy’ in the general population appears to be around 9% for penicillins and 1.3% for cephalosporins.
The incidence of true penicillin allergy (a type I reaction which is immunoglobulin E [IgE] mediated) is <0.05% of the general population. True penicillin allergy can be fatal,with a risk of anaphylaxis estimated in around 0.002% of treated patients. A UK study of drug-induced fatal anaphylaxis between 1992 and 1997 reported 12 deaths due to antibiotics,. Up to 20% of drug-related anaphylaxis deaths in Europe and up to 75% of deaths for all drug-related anaphylaxis in the USA are caused by penicillin,,.
Patients aged 20–49 years are at increased risk of anaphylaxis,, although the reasons are unknown. There is no evidence to suggest a hereditary link to anaphylaxis and therefore family history is irrelevant. Thelatest data suggest there is no link between atopic disease (e.g. patients with asthma, eczema or hay fever) and increased risk of penicillin allergy,, although patients with atopic disease may experience more severe reactions.
A clinical history of penicillin allergy in the more distant past (>15 years) is associated with only a very low risk (0.4%) of reactions, and only 20–30% of patients positive on a penicillin skin test remain positive after ten years.
An allergic reaction is most commonly seen after parenteral administration. Less commonly, penicillin allergy reactions can occur days or weeks after exposure and may persist after treatment has stopped. Other conditions associated with penicillin allergy include serum sickness, drug-induced anaemia, drug reaction with eosinophilia and systemic symptoms (DRESS) and nephritis.
Questions to establish a penicillin allergy
- What was the patient’s age at the time of the reaction?
- Does the patient recall the reaction, and if not, who informed them of it?
- How long after beginning penicillin did the reaction occur?
- What was the route of administration?
- What antibiotics has the patient reacted to in the past?
- What antibiotics has the patient taken and tolerated since the allergy diagnosis?
- What was the nature of the reaction?
- If a rash was present then: a. Describe the nature of the rash (e.g. pustular, urticarial), b. Could the rash be related to an underlying condition (e.g. viral)? c. How long after commencing the antibiotic did the rash appear?
- Why was the patient taking the antibiotic?
- Did this reaction result in hospitalisation?
- Did the reaction resolve on stopping the antibiotic? If so, what happened after stopping the drug?
- What other medications was the patient taking? Why and when were they prescribed?
- Has the patient taken antibiotics similar to penicillin (e.g. amoxicillin, cephalosporins) before or after the reaction? If so, did anything happen?
Histories can be unreliable and can result in over diagnosis of allergy. Some patients may have been too young to fully remember the reaction and patients who report a vague history of symptoms or gastrointestinal intolerance are probably not truly allergic to penicillins. Approximately 80–90% of patients reporting a penicillin allergy are negative when assessed by skin testing. This test can aid in determining a patient’s allergy status and identifying those at high risk of penicillin reactions,.
If a patient reports a rash after ingestion or administration of a medicine containing penicillin, its type can be used to guide whether a related drug (e.g. a cephalosporin or carbapenem) can be used safely. Rashes that involve hives (raised, intensely itchy spots that come and go over hours), or occur with other penicillin allergic symptoms (e.g. wheezing or swelling of the skin or throat), suggest a true penicillin allergy. Rashes that are flat, non-itchy, develop over days and do not change in appearance are less likely to represent a dangerous allergy.
Patients who have experienced a type I allergic reaction with penicillins (e.g. urticaria, laryngeal oedema, bronchospasm, hypotension) should not be prescribed beta-lactam agents including penicillins, cephalosporins, carbapenems or monobactams,.
Cephalosporins and carbapenems can be used with caution in patients that do not have a history of a type I mediated allergic reaction. Cephalosporin allergy is largely dependent on the generation of cephalosporin used. First generation cephalosporins (e.g. cefazolin) were believed to have a cross-reactivity rate of around 10% in patients with a penicillin allergy. However, at the time of these early studies, cephalosporin formulations contained trace amountsof penicillin,,, so this figure is thought to be an overestimate. The true incidence of cross-sensitivity is unknown but there are data to suggest that it is muchlower. Second and third generation cephalosporins (e.g. cefuroxime, ceftriaxone, ceftazidime) have a lower propensity for cross reactivity, as they have different side chains to penicillin, which contribute to the decreased immunogenicity. However, alternatives should be used wherever possible (see below).
Carbapenems (e.g. meropenem, imipenem, ertapenem, doripenem) have a cross reaction rate of 1–6%, in patients who have previously suffered IgE-mediated reactions to penicillins. A thorough clinical history should be taken before prescribing this class of drugs to a patient with known or suspected penicillin allergy.
Aztreonam is a monobactam that does not contain a bicyclic-ring structuresimilar to penicillins, cephalosporins and carbapenems. It can therefore be used safely in patientswith a history of penicillin allergy,,, unless the patient is known to be allergic to ceftazidime, which has an identical side chain to aztreonam,.
Tetracyclines (e.g. doxycycline), macrolides (e.g. clarithromycin), aminoglycosides (e.g. gentamicin), metronidazole, quinolones (e.g. ciprofloxacin) and glycopeptides (e.g. vancomycin) are all unrelated to penicillins and are safe to use in patients with penicillin allergy. However, patients with penicillin allergy are more likely to react to any class of drug,,.
It is a medical emergency if inadvertent administration of penicillin in a patient with known penicillin allergy takes place. The offending drug should be stopped immediately. Anaphylaxis should be treated with adrenaline injection and emergency care to maintain blood pressure and support breathing. A second dose of adrenaline may be required in a small percentage of patients if there is insufficient response. More than two doses are rarely required.
Rashes or hives can be treated with an antihistamine such as chlorpheniramine, although more severe reactions may require treatment with oral or injectable corticosteroids. The severity of the reaction will determine the dose, duration and formulation of treatment.
Following emergency management, patients require close monitoring in hospital for 2–24 hours to ensure they do not develop biphasic anaphylaxis,,,. Biphasic anaphylaxis is the recurrence of symptoms within 1–72 hours with no further exposure to the allergen. The recurrence typically occurs within eight hoursand is managed in the same manner as anaphylaxis.
The risk of inadvertent administration of a medicine known to cause allergy can be minimised by ensuring the patient knows about their condition, and that an accurate medical history is taken before the medicine is prescribed. In hospitals, all inpatients should have known adverse drug reactions included on all patient documents (e.g. drug charts, prescriptions, patient medication records and discharge summaries); this should include information on the nature of the reaction and when it occurred.
If inadvertent administration occurs, the incident should be reviewed to identify the reason and effective safety measures put in place to prevent recurrence. Combination products should also be prescribed generically with their individual constituents to help staff identify when a prescribed medicine may be inappropriate.
Case study 1: assessing history of allergy
Chloe Monroe is a 47-year-old female admitted to hospital for treatment of possible diverticulitis. Chloe’s notes state that she is allergic to penicillin; the nature of the reaction is gastrointestinal disturbance and diarrhoea. On further questioning, she says she gets an “upset stomach” and diarrhoea when taking oral penicillins and will not ingest these medicines. Chloe says she does not experience any itchiness, rash, swelling or other symptoms when taking penicillin. Does Chloe have a penicillin allergy?
Chloe reports gastrointestinal disturbance. This is a known adverse drug reaction but is not a contraindication or true allergy. It is therefore likely that Chloe is intolerant of penicillins, but does not have a penicillin allergy and the medicines can be used safely if required.
Case study 2: treatment options in true allergy
Matthew Bonzer is a 30-year-old patient with a documented history of a penicillin allergy causing an itchy rash. He has been diagnosed with a bacterial respiratory tract infection. What treatment options can be considered?
Matthew has previously experienced symptoms of an allergic reaction to penicillins, therefore a non-penicillin drug should be chosen to treat the infection. Clarithromycin is a macrolide antibiotic and is unrelated to penicillin, and the likelihood of the patient experiencing a reaction is low. He can therefore be started on clarithromycin to treat his respiratory tract infection.
Shilpa Jethwa MSc, MRPharmS, is a specialist pharmacist (antibiotics) at Northwick Park Hospital, London North West Healthcare NHS Trust.
Reading this article counts towards your CPD
You can use the following forms to record your learning and action points from this article from Pharmaceutical Journal Publications.
Your CPD module results are stored against your account here at The Pharmaceutical Journal. You must be registered and logged into the site to do this. To review your module results, go to the ‘My Account’ tab and then ‘My CPD’.
Any training, learning or development activities that you undertake for CPD can also be recorded as evidence as part of your RPS Faculty practice-based portfolio when preparing for Faculty membership. To start your RPS Faculty journey today, access the portfolio and tools at www.rpharms.com/Faculty
If your learning was planned in advance, please click:
If your learning was spontaneous, please click:
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069170
Recommended from Pharmaceutical Press